L-Citrulline | whatsinit

About

What it is and where it shows up.

L-Citrulline is a non-proteinogenic alpha-amino acid and urea-cycle intermediate found naturally at high concentrations in watermelon (Citrullus lanatus), from which its name derives; it is formed by mitochondrial enzymes and serves as a direct precursor for recycling L-arginine. It is widely added to dietary supplements and functional foods to enhance nitric oxide (NO) synthesis, support cardiovascular health, and improve high-intensity exercise performance.

Safety summary

The regulatory and scientific consensus.

Human clinical dose-response studies conducted under the International Council on Amino Acid Science (ICAAS) established a no-observed-adverse-effect level (NOAEL) of 24 g/day in healthy adults, indicating broad tolerability at typical supplemental doses of 3–8 g/day. Long-term safety data beyond six months remain limited, and L-citrulline's ability to augment NO synthesis warrants caution in individuals using antihypertensive medications due to additive blood-pressure-lowering potential. No major regulatory body has established a formal acceptable daily intake (ADI) or tolerable upper intake level (UL), and L-citrulline carries no IARC carcinogenicity classification.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
EFSA (European Food Safety Authority) (European Union)	Approved	L-Citrulline is not included in the EU harmonized positive list of vitamins and minerals permitted in food supplements under Directive 2002/46/EC Annex II; however, it is lawfully marketed as a food supplement ingredient across many EU member states under national provisions and the mutual recognition principle. No EU-wide restriction, ban, or maximum dose limit is in place. EFSA has not issued a stand-alone safety opinion on L-citrulline as of the research date.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Permitted as an amino acid ingredient in health supplements and nutraceuticals under the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Uses, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016 (amended 2021). Only natural L-form amino acids are permitted; suitable esters, derivatives, isomers, and salts of amino acids are also allowed per the 2021 amendment.source
FDA (Food and Drug Administration) (United States)	Approved	Regulated as a dietary supplement ingredient under the Dietary Supplement Health and Education Act (DSHEA) of 1994; not listed as a GRAS substance under 21 CFR Parts 182 or 184 nor as a direct food additive, but neither prohibited nor restricted. Widely marketed in protein powders, pre-workout supplements, and functional beverages without objection.source

Who should approach with care

Whose guidance would steer them away.

Kidney Disease — As a urea-cycle intermediate, impaired renal function can disrupt citrulline and arginine metabolism, potentially causing amino acid accumulation; medical guidance is required before supplementing.

Hypertension — L-Citrulline augments nitric oxide synthesis and may additively potentiate the blood-pressure-lowering effects of antihypertensive medications, increasing the risk of hypotension.

Pregnancy — Supplemental-dose safety during pregnancy has not been adequately studied in humans; preclinical data indicate potential vascular and renal effects in offspring, warranting medical consultation before use.

Infants — No safety data exist for supplemental L-citrulline doses in infants; high-dose amino acid supplementation in this age group requires medical supervision and is not appropriate without a diagnosed metabolic indication.

Liver Disease — The urea cycle, of which L-citrulline is a key intermediate, is primarily hepatic; significant liver impairment may alter citrulline handling and arginine availability unpredictably, necessitating clinical guidance.

Research citations

The sources behind this verdict.

1FDA. Dietary Supplements – FDA Overview and Regulatory Framework. fda.gov
2EFSA. Food Supplements – EFSA Overview and Regulatory Guidance. efsa.europa.eu
3PubMed. Tolerable Upper Intake Level for Individual Amino Acids in Humans: A Narrative Review of Recent Clinical Studies, 2023. pmc.ncbi.nlm.nih.gov
4FSSAI. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Uses, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations – Compendium (September 2021), 2021. fssai.gov.in
5PubMed. l-Citrulline Supplementation: Impact on Cardiometabolic Health, 2018. pmc.ncbi.nlm.nih.gov

Independently researched5 citations